Monthly Archives: December 2018

Artificial Intelligence in Healthcare Spending to Hit $36B

By Jennifer Bresnick December 28, 2018 - The global market for artificial intelligence in healthcare is set for incredible growth over the next few years, according to new research from ReportLinker. The AI in healthcare market is slated to expand from its current $2.1 billion to $36.1 billion in 2025, representing a staggering compound annual growth rate (CAGR) of 50.2

By |2018-12-28T22:25:59+00:00December 28th, 2018|Financial|

DOJ recovered $2.5 billion in 2018 healthcare false claim cases

Dec 26, 2018 / By KEVIN TRUONG As part of the federal government’s increasing focus on issues of healthcare fraud, particularly in the Medicare space, the U.S. Department of Justice recovered $2.5 billion in settlements and judgments from False Claims Act Cases over the past year. According to the DOJ, this is the ninth consecutive year that

By |2018-12-28T18:07:15+00:00December 28th, 2018|Financial|

The Hidden System That Explains How Your Doctor Makes Referrals

Dec. 27, 2018 / By Anna Wilde Mathews and Melanie Evans Phoebe Putney Health System doesn’t want its doctors to send business to competitors. If they do, Phoebe makes sure their bosses know about it. Doctors working for the Albany, Ga.-based hospital system’s affiliated physician group get regular reports breaking down their referrals to specialists or services. One viewed

By |2018-12-28T16:49:44+00:00December 28th, 2018|Financial, Top Stories|

Year in review: The provider mergers that made headlines in 2018

by Paige Minemyer | Dec 26, 2018 Providers have yet to slake their thirst for mergers—with several big-ticket mega-deals dominating headlines in 2018—but experts warn that there’s unlikely to be an immediate pay off for patients. And despite the fast pace of consolidation in healthcare, there are no signs of the merger trend slowing down going into 2019,

By |2018-12-26T21:06:41+00:00December 26th, 2018|Financial|

Hospital prices are about to go public

Dec 26, 2018 / By: Kaitlin Schroeder, Journal-News.com Prices hospitals charge for their services will all go online Jan. 1 under a new federal requirement, but patient advocates say the realities of medical-industry pricing will make it difficult for consumers to get much out of the new data. A federal rule requires all hospitals to post online a

By |2018-12-26T18:09:37+00:00December 26th, 2018|Regulatory|

5 Reasons the 3rd Ortho Value-Based Care Conference Will Be the Best Event You Attend in 2019

12-26-2018 / Kain, Zeev I’m excited to announce the 3rd Interdisciplinary Conference on Orthopedic Value based Care taking place on January 18-20, 2018 in beautiful Newport Beach, California. We’ve planned this conference to be even better than last 2 years highly-rated event! Here’s five reasons it should be on your to-do list: One Unique Team

By |2018-12-26T16:47:48+00:00December 26th, 2018|Recon, Spine|

Published Regenexx Research, Involving Stem Cells And Platelets, Shows Promise For Treating Osteoarthritis Of The Knee

BROOMFIELD, Colo., Dec, 21, 2018 /PRNewswire/ -- New research from Regenexx®, which provides advanced interventional orthobiologics, shows greater potential for treating osteoarthritis of the knee with cell-based therapies. The study, published on December 13, 2018, in the Journal of Translational Medicine, was a randomized controlled trial of patients' own bone marrow concentrate (BMC) and platelet-rich plasma products

By |2018-12-21T16:54:38+00:00December 21st, 2018|Biologics|

Early Reviews of Zimmer Biomet/Apple’s Mymobility App

  December 20, 2018 / Elizabeth Hofheinz, M.P.H., M.Ed. Approximately two months ago, Zimmer Biomet announced the mymobility app which is meant to walk patients through pre- and post-op large joint arthroplasty care. Joshua Carothers, M.D., an orthopedic surgeon at New Mexico Orthopaedics in Albuquerque, is one of the first users of this Zimmer Biomet/Apple product. He shared

By |2018-12-20T19:03:26+00:00December 20th, 2018|Recon|

Conformis readies $21m private placement

DECEMBER 19, 2018 BY SARAH FAULKNER ConforMIS (NSDQ:CFMS) said this week that it inked a deal with Lincoln Park Capital Fund to sell $21 million of shares of the company’s common stock over the course of a 36-month term. According to the terms of the deal, ConforMIS also plans to issue an additional 354,430 shares of common stock

By |2018-12-20T17:19:43+00:00December 20th, 2018|Financial|

FDA sends warning to company for marketing dangerous unapproved stem cell products that put patients at risk and puts other stem cell firms, providers on notice

December 20, 2018 / FDA News Release The U.S. Food and Drug Administration has warned Genetech, Inc. of San Diego, California and its president, Edwin N. Pinos for marketing stem cell products without FDA approval and for significant deviations from current good tissue practice (CGTP) and current good manufacturing practice (CGMP) requirements, including some violations that may

By |2018-12-20T16:57:53+00:00December 20th, 2018|Regulatory, Top Stories|